IGFBP5 and systemic sclerosis: To further understand the role of IGFBP-5 in the development of fibrosis, we silenced endogenous IGFBP-5 in primary human lung fibroblasts derived from lung tissues of normal donors (NL) and patients with IPF or SSc using a sequence-specific siRNA (siBP-5).